Analystreport

Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) had its price target lowered by analysts at Chardan Capital from $5.50 to $4.00. They now have a "buy" rating on the stock.

ARALEZ PHARMACEUTICALS INC COMMON SHARES  (ARLZ) 
Last aralez pharmaceuticals inc common shares earnings: 5/8 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: aralez.com/investors